期刊文献+

P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor 被引量:4

P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor
下载PDF
导出
摘要 AIM:To investigate the role of P115 in the proliferation of gastric cancer cells and the mechanism involved.METHODS:The RNA and protein level of P115 and macrophage migration inhibitory factor(MIF)in gastric cancer and normal gastric tissue/cells were measured and the effect of P115 on cell proliferation was assessed.The role of P115 in cell cycle checkpoints was investigated and the related proteins and signaling pathways,such as cyclin D1,Mcm2,p53,PCNA as well as the MAPK signaling pathway were determined.The interaction between P115 and MIF and the effect of P115 on MIF secretion were examined.The data were analyzed via one-way ANOVA comparisons between groups and P<0.05 was considered significant.RESULTS:P115 and MIF were both specifically expressed in gastric cancer tissues compared with normal gastric mucosa(both P<0.01).The mRNA and protein levels of P115 and MIF in gastric cancer cell lines MKN-28 and BGC-823 were higher than in the human gastric epithelial cell line GES-1(both P<0.01).In MKN-28 and BGC-823 cell lines,P115 promoted cell proliferation and G0-G1to S phase transition.In addition,several cell cycle-related regulators,including cyclin D1,Mcm2,PCNA,pERK1/2 and p53 were up-regulated by P115.Furthermore,the interaction between P115 and MIF was confirmed by co-immunoprecipitation assay.ELISA showed that P115 stimulated the secretion of MIF into the culture supernatant(P<0.01)and the compensative expression of MIF in cells was observed by Western blotting.CONCLUSION:P115 promotes proliferation of gastric cancer cells through an interaction with MIF. AIM: To investigate the role of P115 in the proliferation of gastric cancer cells and the mechanism involved.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第46期8619-8629,共11页 世界胃肠病学杂志(英文版)
关键词 GASTRIC cancer P115 Migration INHIBITORY factor PROLIFERATION Protein INTERACTION Gastric cancer, P115, Migration inhibitory factor, Proliferation, Protein interaction
  • 相关文献

参考文献33

  • 1Meng Zhao,Hong-wei He,Huan-xing Sun,Kai-huan Ren,Rong-guang Shao.Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cells[J]. Biochemical and Biophysical Research Communications . 2009 (2)
  • 2Yu An,Christine Y. Chen,Bryan Moyer,Piotr Rotkiewicz,Marc-André Elsliger,Adam Godzik,Ian A. Wilson,William E. Balch.Structural and Functional Analysis of the Globular Head Domain of p115 Provides Insight into Membrane Tethering[J]. Journal of Molecular Biology . 2009 (1)
  • 3Leilani L. Santos,Eric F. Morand.Macrophage migration inhibitory factor: A key cytokine in RA, SLE and atherosclerosis[J]. Clinica Chimica Acta . 2008 (1)
  • 4Benjamin Short,Alexander Haas,Francis A. Barr.Golgins and GTPases, giving identity and structure to the Golgi apparatus[J]. BBA - Molecular Cell Research . 2005 (3)
  • 5Gunter Fingerle-Rowson,Peter Koch,Rachel Bikoff,Xinchun Lin,Christine N. Metz,Firdaus S. Dhabhar,Andreas Meinhardt,Richard Bucala.Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo[J]. The American Journal of Pathology . 2003 (1)
  • 6Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Journal of Clinical Oncology . 2006
  • 7Waters M G,Clary D O,Rothman J E.A novel 115-kD peripheral membrane protein is required for intercisternal transport in the Golgi stack. Journal of Communication . 1992
  • 8Spoorthy N. Babu,Gaurav Chetal,Sudhir Kumar.Macrophage Migration Inhibitory Factor: a Potential Marker for Cancer Diagnosis and Therapy. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION . 2012
  • 9Shkolnik T,Livni E,Reshef R,Lachter J,Eidelman S.Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions. The American journal of Gastroenterology . 1987
  • 10Al-Abed Yousef,VanPatten Sonya.MIF as a disease target: ISO-1 as a proof-of-concept therapeutic. Future medicinal chemistry . 2011

同被引文献13

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部